These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6166084)

  • 1. The role of primary MLC of the non HLA-D/DR determinant PL3A.
    Termijtelen A; van Rood JJ
    Tissue Antigens; 1981 Jan; 17(1):57-63. PubMed ID: 6166084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavior of HLA-DR homozygous cells in MLC and PLT.
    Zier KS; Gansbacher B; Scholz S; Albert E
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1035-8. PubMed ID: 6168061
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulation in primary MLR caused by a PLT defined non-HLA-D/DR determinant, EP1.
    Holter W; Morling N
    Tissue Antigens; 1983 Jul; 22(1):42-8. PubMed ID: 6193606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new determinant, defined by PLT, coded for in the HLA region and apparently independent of the HLA-D and DR loci.
    Termijtelen A; Bradley BA; van Rood JJ
    Tissue Antigens; 1980 Mar; 15(3):267-74. PubMed ID: 6162224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity of the HLA-D region studied by primed-lymphocyte test.
    Segall M; Reinsmoen NL; Noreen HJ; Bach FH
    J Exp Med; 1980 Aug; 152(2 Pt 2):156s-163s. PubMed ID: 6157765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of matching for SB on MLC typing is significant but marginal.
    Termijtelen A; Naipal-van den Berge S; Suwandi-Thung L; van Rood JJ
    Scand J Immunol; 1984 Mar; 19(3):265-8. PubMed ID: 6231717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal and xenoantibodies specific for HLA-DR inhibit primary responses to HLA-D but fail to inhibit secondary proliferative (PLT) responses to allogeneic cells.
    Eckels DD; Woody JN; Hartzman RJ
    Hum Immunol; 1981 Oct; 3(2):133-42. PubMed ID: 6173360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primed lymphocyte typing predicts MLC reactivity between unrelated individuals.
    Valentine-Thon E; Bach FH
    Tissue Antigens; 1983 Apr; 21(4):336-44. PubMed ID: 6222513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typing for HLA-D determinants. comparison of typing results using homozygous stimulating cells and primed cultures.
    Hirschberg H; Kaakinen A; Thorsby E
    Tissue Antigens; 1976 Apr; 7(4):213-9. PubMed ID: 59960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reactions of primed lymphocytes (PLT) and their genetic determination (author's transl)].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1982 Jan; 94(1):13-9. PubMed ID: 6177103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-D-DR relationships: PLT studies of HLA-D specificities associated with DR1, DR2, and DR4.
    Suciu-Foca N; Godfrey M; Khan R
    Hum Immunol; 1981 Jul; 2(4):295-304. PubMed ID: 6168618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra HLA-D/DR region recombinant detected by primed lymphocyte typing (PLT).
    Jakobsen BK; Kristensen T; Lamm LU; Morling N; Bruun-Petersen G; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1983 Aug; 22(2):123-33. PubMed ID: 6578608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of discriminatory PL against HLA-D antigens not detected by serology.
    Zier KS; Gansbacher B
    Hum Immunol; 1981 Aug; 3(1):57-65. PubMed ID: 6168622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new homozygous typing cell with HLA-D"H" (DB6) specificity. Evidence that the DN-1 monoclonal antibody 9w925 is specific for the HLA-D"H" determinant.
    Jakobsen BK; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1986 May; 27(5):285-90. PubMed ID: 2425455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
    Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
    Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typing for MLC determinants: methods and applications.
    Thomsen M; Ryder LP; Svejgaard A
    Scand J Immunol; 1976 Jun; Suppl 5():157-74. PubMed ID: 79216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new HLA-DRw6- and 8- associated HLA-Dw HAG specificity defined by homozygous typing cell 9W 1802. Analysis with primed lymphocyte typing clones.
    Pawelec G; Müller C; Rehbein A; Balko I; Schunter F; Wernet P
    Tissue Antigens; 1984 Nov; 24(5):292-301. PubMed ID: 6085195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloned primed-lymphocyte-test reagents in the dissection of HLA-D.
    Inouye H; Hank JA; Chardonnens X; Segall M; Alter BJ; Bach FH
    J Exp Med; 1980 Aug; 152(2 Pt 2):143s-155s. PubMed ID: 6157764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population studies of HLA-linked SB antigens and their relative importance in primary MLC typing. Analysis of HLA-D homozygous typing cells and normal heterozygous populations.
    Pawelec G; Shaw S; Schneider M; Blaurock M; Frauer M; Brackertz D; Wernet P
    Hum Immunol; 1982 Nov; 5(3):215-23. PubMed ID: 6217174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological distinction between DR antigens and lymphocyte activating determinants.
    van Heyningen V; Cohen BB; Deane DL; Gray C; Steel CM
    Tissue Antigens; 1981 Feb; 17(2):149-61. PubMed ID: 6165093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.